Angeles Therapeutics

Angeles Therapeutics

CA - Los Angeles
Biotechnology1 H-1B visas (FY2023)
WebsiteLinkedIn

Focus: CAR T, NK Platform

Angeles Therapeutics is a life sciences company focused on CAR T, NK Platform.

Cell Therapy
Open Jobs
0

Products & Portfolio (2)

FLUDEOXYGLUCOSE F18
fludeoxyglucose f-18
Post-LOE
INTRAVENOUS · INJECTABLE
Radiopharmaceutical Activity
2014
30
GALLIUM GA 68 GOZETOTIDE
gallium ga-68 gozetotide
Peak
PeptideINTRAVENOUS · SOLUTION
Positron Emitting Activity
2020
30

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts
Founded: 2021
Portfolio: 2 approved products, 6 clinical trials
Top TAs: Infectious Diseases, Neurology
H-1B (2023): 1 approval
Portfolio Health
Peak1 (50%)
Post-LOE1 (50%)
2 total products
Therapeutic Area Focus
Neurology
1 pipeline
Marketed
Pipeline

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub